NIC Notes

Insights in Seniors Housing & Care

COVID-19  |  Market Trends

2Q2020 Seniors Housing Actual Rates Report Key Takeaways

By: Anne Standish  |  September 09, 2020

The NIC MAP® Data Service recently released national monthly data through June 2020 for actual rates and leasing velocity. In this release, NIC also provided data on three metropolitan areas for which there is enough data to report:  Atlanta, Philadelphia, and Phoenix.

COVID-19  |  Executive Survey Insights

Executive Survey Insights | Wave 11: August 17 to August 30, 2020

By: Lana Peck  |  September 03, 2020

NIC’s Executive Survey of operators in seniors housing and skilled nursing is designed to deliver transparency into market fundamentals in the seniors housing and care space at a time when market conditions are rapidly changing—providing both capital providers and capital seekers with data as to how COVID-19 is impacting the sector.

COVID-19  |  Seniors Housing  |  Skilled Nursing  |  Workforce

Staff Mental Fatigue and Burnout: The Hidden Toll of COVID-19

By: Ryan Brooks  |  August 26, 2020

A recent study from North Carolina State University and Georgia Tech found that healthcare workers in the United States are struggling with significant mental-health challenges during the COVID-19 pandemic, including depression, anxiety, and insomnia. While all healthcare workers are at risk, one key feature of caregivers in a seniors housing and care setting is that many of these caregivers have spent months, if not years, developing relationships with the residents they serve and their families. This means the emotional toll experienced by these staff may be that much more overwhelming.

COVID-19

COVID-19 Testing Method Discussed in NIC Leadership Huddle Gains FDA Approval

By: NIC  |  August 20, 2020

Late last month, NIC’s Leadership Huddle webinar, “From Pro Sports to Senior Care: Innovations in Testing, Tech, and Protection,” offered a glimpse into the future of COVID-19 testing with a discussion of the saliva-based test under development at Yale University and funded by the NBA and the National Basketball Players Association. The Food and Drug Administration (FDA) this week issued an emergency use authorization approval allowing public use of the test.